LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹38 Cr | ₹11 Cr | ₹26 Cr | ₹43 Cr | ₹28 Cr |
What is the latest Total Non-Current Liabilities ratio of LINCOLN PHARMACEUTICALS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹38 Cr |
Mar2022 | ₹11 Cr |
Mar2021 | ₹26 Cr |
Mar2020 | ₹43 Cr |
Mar2019 | ₹28 Cr |
How is Total Non-Current Liabilities of LINCOLN PHARMACEUTICALS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹38 Cr | 244.54 | |
Mar2022 | ₹11 Cr | -57.89 | |
Mar2021 | ₹26 Cr | -39.08 | |
Mar2020 | ₹43 Cr | 50.70 | |
Mar2019 | ₹28 Cr | - |
Compare Total Non-Current Liabilities of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,194.2 Cr | -0.1% | -0.3% | 52% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -0.1% |
-0.3% |
52% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses